Tango Therapeutics Inc (TNGX)
7.61
+0.02
(+0.26%)
USD |
NASDAQ |
May 03, 16:00
7.615
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Net Income (TTM): -101.74M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -101.74M |
September 30, 2023 | -100.04M |
June 30, 2023 | -106.83M |
March 31, 2023 | -110.98M |
December 31, 2022 | -108.18M |
September 30, 2022 | -101.16M |
Date | Value |
---|---|
June 30, 2022 | -91.70M |
March 31, 2022 | -71.34M |
December 31, 2021 | -58.24M |
September 30, 2021 | -45.05M |
June 30, 2021 | -52.26M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-110.98M
Minimum
Mar 2023
-45.05M
Maximum
Sep 2021
-86.14M
Average
-100.04M
Median
Sep 2023
Net Income (TTM) Benchmarks
Aquestive Therapeutics Inc | -7.87M |
2seventy bio Inc | -217.57M |
NovaBay Pharmaceuticals Inc | -9.64M |
Palatin Technologies Inc | -31.59M |
iBio Inc | -27.28M |